B Medical Systems highlights the importance of ultra-low temperature storage for preserving cancer biomarkers

fr en

The use of tumor markers in diagnosing, assessing prognosis, and selecting appropriate cancer treatments has revolutionized the field of molecular diagnostics. However, the integrity of these biomarkers during processing and storage is crucial to ensure accurate and reliable results. In a publication, B Medical Systems sheds light on the paramount importance of ultra-low temperature storage in safeguarding the stability of essential cancer biomarkers found in fluid, cell, and tissue biospecimens. 

<< Back
05/07/2023 |
  • Bmedical-20-26 resized-1024x683-1

By delving into the preservation of tissue nucleic acids and proteins, as well as circulating tumor markers, B Medical Systems provides valuable insights for the medical and scientific communities. Luc Provost, the company CEO, emphasizes the importance of maintaining stability and quality in cancer research. He states, "In cancer research, the storage of samples via ultra-low temperature freezers is critical. Many biomarkers require stability and quality, as various studies have demonstrated in our white paper. If biospecimens are used mainly for DNA and protein analysis, long-term storage at temperatures between ?70°C or ?80°C can be effective. To achieve this level of uniformity of temperature and sample safety, investments need to be made in cold chain infrastructure."

Tissue nucleic acids and proteins play a vital role in cancer biomarker testing. The ultra-low temperature storage of tissue samples at or below ?70°C or ?80°C ensures high-quality nucleic acids and preserves the proteome profiles, enabling accurate analysis of DNA, RNA, and proteins[1].

Circulating tumor markers, such as circulating free DNA (cfDNA), are also crucial indicators for cancer diagnostics. The preservation of plasma samples at very cold temperatures, along with the avoidance of freeze-thaw cycles, enables reliable analysis of these markers. Proper storage at ultra-low temperatures provides the stability of nucleic acids and other tumor indicators[2].

As a global manufacturer and distributor of reliable Ultra-Low Freezers, B Medical Systems understands the critical importance of maintaining the stability and quality of biomarkers in cancer research. The company’s technology-packed storage solutions offer precise temperature control, uniformity, and enhanced sample safety. The company's commitment to compliance with regulations ensures the production of high-quality medical devices. 

Securing the state-of-the-art cold chain infrastructure is crucial for researchers and healthcare professionals to ensure the integrity and reliability of cancer biomarkers, and ultimately advancing the field of oncology.

To download the free white paper: https://www.bmedicalsystems.com/en/white-papers/stability-of-cancer-biomarkers-under-ultra-low-temperature-storage/

Back to top  | << Back

Communiqués liés

RSA Erik Lindeman

RSA launches technology and management liability insurance s...

RSA Luxembourg, part of Intact Insurance Specialty Solutions, today announces th...

RSA
Terminal Bettembourg-Dudelange Copyright CFL multimodal
10/09/2024

Lancement d'une nouvelle connexion intermodale entre Bettemb...

CFL multimodal a le plaisir d'annoncer le lancement de sa  nouvelle connexion i...

CFL multimodal
 DSC5136 ABI Graduate
09/09/2024

Experts from LUNEX award first micro-credentials in Rwanda o...

The Rwanda Ministry of Education (MINEDUC) formally inaugurated Syllabi, a publi...

Lunex
ERG's logo (002)
09/09/2024

ERG Notes that ENRC Secures Landmark Victory as Court of App...

Eurasian Resources Group (ERG), a leading diversified natural resources group he...

Eurasian Resources Group
Pierre Thomas X Jean-Paul Scheuren
03/09/2024 Partenariat

LetzToken et La Vie est Belle annoncent leur partenariat ouv...

«?LetzToken?», plateforme de tokenisation pionnière basée à Luxembourg, et ...

LetzToken
Metalkol
02/09/2024

ERG announces a Pre-Export Finance Facility Agreement based ...

Eurasian Resources Group (“ERG”, “The Group”), a leading diversified nat...

Eurasian Resources Group

Il n'y a aucun résultat pour votre recherche

We use cookies to ensure the best experience on our website. By accepting you agree the use of cookies. OK Learn more